Housekeeping note: Please do not post any further PRs whose sole content is the granting of Breakthrough Therapy status for some drug. This one from Genmab was the last straw
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.